Media presence is a key part of making society aware of developments in biotechnology and its benefits. AseBio makes this platform available to members so they can share their press releases, alongside those the association posts regularly. If you are a journalist interested in learning more about the biotechnology sector, contact us at AseBio.
3P Biopharmaceuticals together with the Swedish biotechnology company Intervacc AB and LIOF-Pharma (previously Praxis Pharmaceutical), completed the manufacturing process for the vaccine against equine strangles called Strangvac.
XIIIth Spanish-Portuguese Conference on Controlled Drug Delivery will be held from January 22-24th, 2020 at the University of Santiago de Compostela
Agreement strengthens collaboration between the companies following submission of the first dossier to the European Medicines Agency (EMA) for a CrisBio® produced recombinant vaccine
It´s for the project “UNLOCK-EDD: UNLOCK next generation computer guided Enzyme Discovery & Design”
We are pleased to announce David Ovelleiro as our new Senior Bioinformatician
One of our goals is to count on the best professionals in order to offer excellence in our services and products.